Tempus Wealth Planning LLC Acquires 141 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tempus Wealth Planning LLC raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 30,892 shares of the company’s stock after buying an additional 141 shares during the quarter. GE HealthCare Technologies comprises 1.0% of Tempus Wealth Planning LLC’s portfolio, making the stock its 21st largest holding. Tempus Wealth Planning LLC’s holdings in GE HealthCare Technologies were worth $2,407,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in GEHC. US Bancorp DE lifted its position in GE HealthCare Technologies by 83.4% in the fourth quarter. US Bancorp DE now owns 146,524 shares of the company’s stock worth $11,329,000 after buying an additional 66,638 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in shares of GE HealthCare Technologies by 23.7% during the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 97,127 shares of the company’s stock worth $7,510,000 after purchasing an additional 18,634 shares during the period. Global Assets Advisory LLC bought a new position in GE HealthCare Technologies during the 1st quarter valued at about $4,273,000. Vanguard Group Inc. raised its position in GE HealthCare Technologies by 9.2% in the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after purchasing an additional 4,107,746 shares during the period. Finally, Hsbc Holdings PLC lifted its stake in GE HealthCare Technologies by 21.1% in the fourth quarter. Hsbc Holdings PLC now owns 470,993 shares of the company’s stock worth $36,408,000 after purchasing an additional 81,916 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the sale, the chief technology officer now owns 67,300 shares in the company, valued at approximately $5,296,510. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the transaction, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Stock Up 0.5 %

GEHC stock traded up $0.41 during trading on Friday, reaching $84.78. 1,511,760 shares of the company traded hands, compared to its average volume of 3,015,838. The business has a 50 day simple moving average of $80.77 and a 200 day simple moving average of $83.41. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.83 and a current ratio of 1.06. The company has a market capitalization of $38.70 billion, a price-to-earnings ratio of 24.79, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The firm had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.92 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend was Friday, July 19th. GE HealthCare Technologies’s payout ratio is presently 3.51%.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Bank of America reduced their target price on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. The Goldman Sachs Group assumed coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They set a “neutral” rating and a $87.00 target price for the company. Mizuho reduced their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Finally, Stifel Nicolaus assumed coverage on GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target for the company. Five investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus target price of $95.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.